Elizabeth Iorns

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 712 citations · Full text

Endocrine Oncology, Breast Oncology, Endocrine-related Cancer +14

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

Nicholas C. Turner, Christopher J. Lord, Elizabeth Iorns et al. · The EMBO Journal · 2008 · 323 citations · Full text

Parp Inhibitor, Natural Sciences, Genetics +8

An open investigation of the reproducibility of cancer biology research

Timothy M. Errington, Elizabeth Iorns, William G. Gunn et al. · eLife · 2014 · 321 citations · Full text

Reproducibility Studies, Open Methodology, Engineering +16

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

Elizabeth Iorns, Nicholas C. Turner, Richard Elliott et al. · Cancer Cell · 2008 · 228 citations · Full text

Breast Oncology, Oncology, Medicine +10

A New Mouse Model for the Study of Human Breast Cancer Metastasis

Elizabeth Iorns, Katherine Drews‐Elger, Toby M. Ward et al. · PLoS ONE · 2012 · 154 citations · Full text

Breast Cancer Metastasis, Systems Biology, Oncology +14